Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Boyd

Showing results (531-540 of 565) with videos related to

Pageof 57
Sort By:
Plos Genetics|July 3, 2013
The genome of tolypocladium inflatum: evolution, organization, and expression of the cyclosporin biosynthetic gene clusterKathryn E Bushley, Rajani Raja, Pankaj Jaiswal, et al.
Journal of Medicinal Chemistry|December 22, 1999
Alpha(2) adrenoceptor agonists as potential analgesic agents. 1. (Imidazolylmethyl)oxazoles and -thiazolesR E Boyd, J B Press, C R Rasmussen, et al.
Cancer|September 16, 2011
The impact of biomarkers in multivariate algorithms for bladder cancer diagnosis in patients with hematuriaFunso Abogunrin, Hugh F O'Kane, Mark W Ruddock, et al.
Fertility and Sterility|September 1, 1979
Prolonged amenorrhea and oral contraceptivesG Tolis, D Ruggere, D R Popkin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 10, 2012
Bruton tyrosine kinase inhibitor ibrutinib (PCI-32765) has significant activity in patients with relapsed/refractory B-cell malignanciesRanjana H Advani, Joseph J Buggy, Jeff P Sharman, et al.
Journal of Medicinal Chemistry|December 7, 2010
Phthalazinone pyrazoles as potent, selective, and orally bioavailable inhibitors of Aurora-A kinaseMichael E Prime, Stephen M Courtney, Frederick A Brookfield, et al.
Hemasphere|November 15, 2019
Idelalisib in Combination With Rituximab or Bendamustine or Both in Patients With Relapsed/Refractory Chronic Lymphocytic LeukemiaSteven E Coutre, Ian W Flinn, Sven de Vos, et al.
Bioinformatics (Oxford, England)|May 15, 2012
Software support for SBGN maps: SBGN-ML and LibSBGNMartijn P van Iersel, Alice C Villéger, Tobias Czauderna, et al.
The Lancet Regional Health. Europe|April 14, 2025
Evolving antimicrobial resistance of extensively drug-resistant Gram-negative severe infections associated with conflict wounds in Ukraine: an observational studyScott J C Pallett, Anna Morkowska, Stephen D Woolley, et al.
Neurogenetics|March 25, 2000
Locus heterogeneity, anticipation and reduction of the chromosome 2p minimal candidate region in autosomal dominant familial spastic paraplegiaW K Scott, P C Gaskell, F Lennon, et al.
Pageof 57

Showing results (531-540 of 565) with videos related to

Sort By:
Pageof 57
Plos Genetics|July 3, 2013
The genome of tolypocladium inflatum: evolution, organization, and expression of the cyclosporin biosynthetic gene clusterKathryn E Bushley, Rajani Raja, Pankaj Jaiswal, et al.
Journal of Medicinal Chemistry|December 22, 1999
Alpha(2) adrenoceptor agonists as potential analgesic agents. 1. (Imidazolylmethyl)oxazoles and -thiazolesR E Boyd, J B Press, C R Rasmussen, et al.
Cancer|September 16, 2011
The impact of biomarkers in multivariate algorithms for bladder cancer diagnosis in patients with hematuriaFunso Abogunrin, Hugh F O'Kane, Mark W Ruddock, et al.
Fertility and Sterility|September 1, 1979
Prolonged amenorrhea and oral contraceptivesG Tolis, D Ruggere, D R Popkin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 10, 2012
Bruton tyrosine kinase inhibitor ibrutinib (PCI-32765) has significant activity in patients with relapsed/refractory B-cell malignanciesRanjana H Advani, Joseph J Buggy, Jeff P Sharman, et al.
Journal of Medicinal Chemistry|December 7, 2010
Phthalazinone pyrazoles as potent, selective, and orally bioavailable inhibitors of Aurora-A kinaseMichael E Prime, Stephen M Courtney, Frederick A Brookfield, et al.
Hemasphere|November 15, 2019
Idelalisib in Combination With Rituximab or Bendamustine or Both in Patients With Relapsed/Refractory Chronic Lymphocytic LeukemiaSteven E Coutre, Ian W Flinn, Sven de Vos, et al.
Bioinformatics (Oxford, England)|May 15, 2012
Software support for SBGN maps: SBGN-ML and LibSBGNMartijn P van Iersel, Alice C Villéger, Tobias Czauderna, et al.
The Lancet Regional Health. Europe|April 14, 2025
Evolving antimicrobial resistance of extensively drug-resistant Gram-negative severe infections associated with conflict wounds in Ukraine: an observational studyScott J C Pallett, Anna Morkowska, Stephen D Woolley, et al.
Neurogenetics|March 25, 2000
Locus heterogeneity, anticipation and reduction of the chromosome 2p minimal candidate region in autosomal dominant familial spastic paraplegiaW K Scott, P C Gaskell, F Lennon, et al.
Pageof 57